Literature DB >> 28875245

The relation of somatotypes and stress response to central serous chorioretinopathy.

Roy Schwartz1, Assaf Rozenberg2, Anat Loewenstein3, Michaella Goldstein3.   

Abstract

PURPOSE: To investigate a possible relationship between central serous chorioretinopathy (CSC) and specific body types and compositions (somatotypes), and to examine the cortisol stress response among CSC patients of different somatotypes in comparison with healthy subjects.
METHODS: Prospective case-control study. A group of 28 patients with a previous or current diagnosis of CSC was compared with a group of 26 healthy subjects. Anthropometric measurements were used to estimate somatotype ratings in all subjects. Serum cortisol was measured at rest and following a stress-inducing computerized test in order to estimate response to stress in both groups. The main outcome measures included somatotype categorization and the change in serum cortisol following stress in both groups.
RESULTS: No significant difference in somatotype composition was found between the groups. There was no statistically significant difference between the groups in the elevation of cortisol following the stress-inducing test. The sample size was too small to exclude or find any significant difference between the different 13 subgroups of somatotype composition in the elevation of cortisol.
CONCLUSIONS: Our study did not show a typical somatotype related to CSC. While previous studies showed higher cortisol values in CSC patients, we did not see a higher elevation in blood cortisol following a stress response in this group in comparison with healthy subjects.

Entities:  

Keywords:  Body composition; CSC; Central serous chorioretinopathy; Cortisol; Somatotypes; Stroop

Mesh:

Substances:

Year:  2017        PMID: 28875245     DOI: 10.1007/s00417-017-3787-6

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  35 in total

1.  Central serous chorioretinopathy associated with a carcinoma of the adrenal cortex.

Authors:  A M Thoelen; P P Bernasconi; C Schmid; E P Messmer
Journal:  Retina       Date:  2000       Impact factor: 4.256

2.  The impact of financial crisis on central serous chorioretinopathy in Greece: is there any correlation?

Authors:  Alexandros A Rouvas; Irini P Chatziralli; Ioannis D Ladas; Vivi Xanthopoulou; Emmanouela Giannakaki; Aikaterini Karamboula; Dimitrios Galanis; Ioannis Datseris; Dimitrios Alonistiotis; Ramza Diamanti; Miltiadis Tsilimbaris; Aikaterini Chalkia; Panagiotis Theodossiadis
Journal:  Eur J Ophthalmol       Date:  2013-12-09       Impact factor: 2.597

3.  Familial chronic central serous chorioretinopathy.

Authors:  A C Weenink; R A Borsje; J A Oosterhuis
Journal:  Ophthalmologica       Date:  2001 May-Jun       Impact factor: 3.250

4.  Central serous chorioretinopathy associated with inhaled or intranasal corticosteroids.

Authors:  R Haimovici; E S Gragoudas; J S Duker; R N Sjaarda; D Eliott
Journal:  Ophthalmology       Date:  1997-10       Impact factor: 12.079

5.  Central serous chorioretinopathy after solid organ transplantation.

Authors:  Amani A Fawzi; Gary N Holland; Allan E Kreiger; John R Heckenlively; Jorge G Arroyo; Emmett T Cunningham
Journal:  Ophthalmology       Date:  2006-05       Impact factor: 12.079

Review 6.  Type-A behavior and central serous chorioretinopathy.

Authors:  L A Yannuzzi
Journal:  Retina       Date:  1987       Impact factor: 4.256

7.  Central serous chorioretinopathy in endogenous hypercortisolism.

Authors:  E A Bouzas; M H Scott; G Mastorakos; G P Chrousos; M I Kaiser-Kupfer
Journal:  Arch Ophthalmol       Date:  1993-09

8.  Somatotype in elderly type 2 diabetes patients.

Authors:  Roberto Buffa; Giovanni Floris; Paolo F Putzu; Luciano Carboni; Elisabetta Marini
Journal:  Coll Antropol       Date:  2007-09

9.  Central serous chorioretinopathy complicating systemic corticosteroid therapy.

Authors:  A M Abu el-Asrar
Journal:  Eur J Ophthalmol       Date:  1997 Jul-Sep       Impact factor: 1.922

10.  Serum cortisol and testosterone levels in idiopathic central serous chorioretinopathy.

Authors:  Shaik M Zakir; M Shukla; Zaka-Ur-Rab Simi; J Ahmad; Mahmood Sajid
Journal:  Indian J Ophthalmol       Date:  2009 Nov-Dec       Impact factor: 1.848

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.